Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque Model.

Goswami R, Nelson AN, Tu JJ, Dennis M, Feng L, Kumar A, Mangold J, Mangan RJ, Mattingly C, Curtis AD 2nd, Obregon-Perko V, Mavigner M, Pollara J, Shaw GM, Bar KJ, Chahroudi A, De Paris K, Chan C, Van Rompay KKA, Permar SR.

MBio. 2019 Sep 5;10(5). pii: e01971-19. doi: 10.1128/mBio.01971-19.

2.

Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon γ and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 Infection.

Loiseau C, Requena M, Nayrac M, Mavigner M, Cazabat M, Iscache AL, Carrere N, Suc B, Alric L, Izopet J, Delobel P.

J Infect Dis. 2019 Jul 31;220(5):830-840. doi: 10.1093/infdis/jiz123.

PMID:
30880342
3.

Correction for Mavigner et al., "Simian Immunodeficiency Virus Persistence in Cellular and Anatomic Reservoirs in Antiretroviral Therapy-Suppressed Infant Rhesus Macaques".

Mavigner M, Habib J, Deleage C, Rosen E, Mattingly C, Bricker K, Kashuba A, Amblard F, Schinazi RF, Lawson B, Vanderford TH, Jean S, Cohen J, McGary C, Paiardini M, Wood MP, Sodora DL, Silvestri G, Estes J, Chahroudi A.

J Virol. 2019 Jan 17;93(3). pii: e01814-18. doi: 10.1128/JVI.01814-18. Print 2019 Feb 1. No abstract available.

4.

Antibody-Mediated CD4 Depletion Induces Homeostatic CD4+ T Cell Proliferation without Detectable Virus Reactivation in Antiretroviral Therapy-Treated Simian Immunodeficiency Virus-Infected Macaques.

Kumar NA, McBrien JB, Carnathan DG, Mavigner M, Mattingly C, White ER, Viviano F, Bosinger SE, Chahroudi A, Silvestri G, Paiardini M, Vanderford TH.

J Virol. 2018 Oct 29;92(22). pii: e01235-18. doi: 10.1128/JVI.01235-18. Print 2018 Nov 15.

5.

Simian Immunodeficiency Virus Persistence in Cellular and Anatomic Reservoirs in Antiretroviral Therapy-Suppressed Infant Rhesus Macaques.

Mavigner M, Habib J, Deleage C, Rosen E, Mattingly C, Bricker K, Kashuba A, Amblard F, Schinazi RF, Lawson B, Vanderford TH, Jean S, Cohen J, McGary C, Paiardini M, Wood MP, Sodora DL, Silvestri G, Estes J, Chahroudi A.

J Virol. 2018 Aug 29;92(18). pii: e00562-18. doi: 10.1128/JVI.00562-18. Print 2018 Sep 15. Erratum in: J Virol. 2019 Jan 17;93(3):.

6.

Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques.

Palesch D, Bosinger SE, Mavigner M, Billingsley JM, Mattingly C, Carnathan DG, Paiardini M, Chahroudi A, Vanderford TH, Silvestri G.

J Virol. 2018 Jun 29;92(14). pii: e00279-18. doi: 10.1128/JVI.00279-18. Print 2018 Jul 15.

7.

Postnatal Zika virus infection is associated with persistent abnormalities in brain structure, function, and behavior in infant macaques.

Mavigner M, Raper J, Kovacs-Balint Z, Gumber S, O'Neal JT, Bhaumik SK, Zhang X, Habib J, Mattingly C, McDonald CE, Avanzato V, Burke MW, Magnani DM, Bailey VK, Watkins DI, Vanderford TH, Fair D, Earl E, Feczko E, Styner M, Jean SM, Cohen JK, Silvestri G, Johnson RP, O'Connor DH, Wrammert J, Suthar MS, Sanchez MM, Alvarado MC, Chahroudi A.

Sci Transl Med. 2018 Apr 4;10(435). pii: eaao6975. doi: 10.1126/scitranslmed.aao6975.

8.

Liver macrophage-associated inflammation correlates with SIV burden and is substantially reduced following cART.

Fisher BS, Green RR, Brown RR, Wood MP, Hensley-McBain T, Fisher C, Chang J, Miller AD, Bosche WJ, Lifson JD, Mavigner M, Miller CJ, Gale M Jr, Silvestri G, Chahroudi A, Klatt NR, Sodora DL.

PLoS Pathog. 2018 Feb 21;14(2):e1006871. doi: 10.1371/journal.ppat.1006871. eCollection 2018 Feb.

9.

In Vivo Models of Human Immunodeficiency Virus Persistence and Cure Strategies.

Nixon CC, Mavigner M, Silvestri G, Garcia JV.

J Infect Dis. 2017 Mar 15;215(suppl_3):S142-S151. doi: 10.1093/infdis/jiw637. Review.

10.

Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection.

Mylvaganam GH, Rios D, Abdelaal HM, Iyer S, Tharp G, Mavigner M, Hicks S, Chahroudi A, Ahmed R, Bosinger SE, Williams IR, Skinner PJ, Velu V, Amara RR.

Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):1976-1981. doi: 10.1073/pnas.1621418114. Epub 2017 Feb 3. Erratum in: Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):E3366. Mavinger, Maud [corrected to Mavigner, Maud].

11.

Quantifying integrated SIV-DNA by repetitive-sampling Alu-gag PCR.

Mavigner M, Lee ST, Habib J, Robinson C, Silvestri G, O'Doherty U, Chahroudi A.

J Virus Erad. 2016 Oct 5;2(4):219-226.

12.

Initiation of Antiretroviral Therapy Restores CD4+ T Memory Stem Cell Homeostasis in Simian Immunodeficiency Virus-Infected Macaques.

Cartwright EK, Palesch D, Mavigner M, Paiardini M, Chahroudi A, Silvestri G.

J Virol. 2016 Jul 11;90(15):6699-6708. doi: 10.1128/JVI.00492-16. Print 2016 Aug 1.

13.

CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individuals.

Loiseau C, Requena M, Mavigner M, Cazabat M, Carrere N, Suc B, Barange K, Alric L, Marchou B, Massip P, Izopet J, Delobel P.

Mucosal Immunol. 2016 Sep;9(5):1137-50. doi: 10.1038/mi.2016.7. Epub 2016 Feb 17.

PMID:
26883727
14.

Reduced Simian Immunodeficiency Virus Replication in Macrophages of Sooty Mangabeys Is Associated with Increased Expression of Host Restriction Factors.

Mir KD, Mavigner M, Wang C, Paiardini M, Sodora DL, Chahroudi AM, Bosinger SE, Silvestri G.

J Virol. 2015 Oct;89(20):10136-44. doi: 10.1128/JVI.00710-15. Epub 2015 Jul 22.

15.

Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant.

Mavigner M, Watkins B, Lawson B, Lee ST, Chahroudi A, Kean L, Silvestri G.

PLoS Pathog. 2014 Sep 25;10(9):e1004406. doi: 10.1371/journal.ppat.1004406. eCollection 2014 Sep.

16.

Target cell availability, rather than breast milk factors, dictates mother-to-infant transmission of SIV in sooty mangabeys and rhesus macaques.

Chahroudi A, Cartwright E, Lee ST, Mavigner M, Carnathan DG, Lawson B, Carnathan PM, Hashempoor T, Murphy MK, Meeker T, Ehnert S, Souder C, Else JG, Cohen J, Collman RG, Vanderford TH, Permar SR, Derdeyn CA, Villinger F, Silvestri G.

PLoS Pathog. 2014 Mar 6;10(3):e1003958. doi: 10.1371/journal.ppat.1003958. eCollection 2014 Mar.

17.

The myeloid cytokine network in AIDS pathogenesis.

Mir KD, Mavigner M, Silvestri G.

Cytokine Growth Factor Rev. 2012 Aug-Oct;23(4-5):223-31. doi: 10.1016/j.cytogfr.2012.05.009. Epub 2012 Jun 28. Review.

PMID:
22748236
18.

Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals.

Mavigner M, Cazabat M, Dubois M, L'Faqihi FE, Requena M, Pasquier C, Klopp P, Amar J, Alric L, Barange K, Vinel JP, Marchou B, Massip P, Izopet J, Delobel P.

J Clin Invest. 2012 Jan;122(1):62-9. doi: 10.1172/JCI59011. Epub 2011 Dec 12.

19.

CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression.

Raymond S, Delobel P, Mavigner M, Cazabat M, Encinas S, Souyris C, Bruel P, Sandres-Sauné K, Marchou B, Massip P, Izopet J.

AIDS. 2010 Sep 24;24(15):2305-12. doi: 10.1097/QAD.0b013e32833e50bb.

PMID:
20808203
20.

Shift in phenotypic susceptibility suggests a competition mechanism in a case of acquired resistance to maraviroc.

Delobel P, Raymond S, Mavigner M, Cazabat M, Alvarez M, Marchou B, Massip P, Izopet J.

AIDS. 2010 Jun 1;24(9):1382-4. doi: 10.1097/QAD.0b013e328338b7a6. No abstract available.

PMID:
20559045
21.

Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage.

Raymond S, Delobel P, Mavigner M, Cazabat M, Souyris C, Encinas S, Bruel P, Sandres-Sauné K, Marchou B, Massip P, Izopet J.

J Clin Virol. 2010 Feb;47(2):126-30. doi: 10.1016/j.jcv.2009.11.018. Epub 2009 Dec 16.

PMID:
20015684
22.

Prediction of HIV type 1 subtype C tropism by genotypic algorithms built from subtype B viruses.

Raymond S, Delobel P, Mavigner M, Ferradini L, Cazabat M, Souyris C, Sandres-Sauné K, Pasquier C, Marchou B, Massip P, Izopet J.

J Acquir Immune Defic Syndr. 2010 Feb;53(2):167-75. doi: 10.1097/QAI.0b013e3181c8413b.

PMID:
19996764
23.

HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.

Mavigner M, Delobel P, Cazabat M, Dubois M, L'faqihi-Olive FE, Raymond S, Pasquier C, Marchou B, Massip P, Izopet J.

PLoS One. 2009 Oct 30;4(10):e7658. doi: 10.1371/journal.pone.0007658.

24.

Genotypic prediction of human immunodeficiency virus type 1 CRF02-AG tropism.

Raymond S, Delobel P, Mavigner M, Cazabat M, Souyris C, Encinas S, Sandres-Sauné K, Pasquier C, Marchou B, Massip P, Izopet J.

J Clin Microbiol. 2009 Jul;47(7):2292-4. doi: 10.1128/JCM.02439-08. Epub 2009 May 13.

25.

Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism.

Raymond S, Delobel P, Mavigner M, Cazabat M, Souyris C, Sandres-Sauné K, Cuzin L, Marchou B, Massip P, Izopet J.

AIDS. 2008 Sep 12;22(14):F11-6. doi: 10.1097/QAD.0b013e32830ebcd4.

PMID:
18753930

Supplemental Content

Loading ...
Support Center